Premium Nahrungsergänzungsmittel | artgerecht

Pseudochylothorax – Causes, Symptoms and Treatment

Pseudochylothorax is a rare condition in which a milky, turbid fluid accumulates in the pleural space, resembling chyle but characterized by high cholesterol levels.

Regular tips about health Regular tips about health

Things worth knowing about "Pseudochylothorax"

Pseudochylothorax is a rare condition in which a milky, turbid fluid accumulates in the pleural space, resembling chyle but characterized by high cholesterol levels.

What is Pseudochylothorax?

Pseudochylothorax (also known as chyliform pleural effusion) is a rare type of pleural effusion in which a milky, turbid fluid accumulates in the pleural space – the thin cavity between the lungs and the chest wall. Unlike a true chylothorax, which is caused by leaking lymphatic fluid (chyle) and is characterized by elevated triglyceride levels, pseudochylothorax is distinguished by very high concentrations of cholesterol or lecithin-globulin complexes. The condition typically develops slowly over months to years as a consequence of a chronic pleural effusion.

Causes

Pseudochylothorax usually develops from a longstanding, untreated pleural effusion in which cholesterol crystals accumulate in the pleural fluid. Common underlying conditions include:

Tuberculosis (most common cause worldwide)
Rheumatoid arthritis with chronic pleural effusion
Empyema (purulent infection of the pleural space)
Paragonimiasis (infection by the lung fluke)
Malignancy (cancers affecting the chest)
Trauma or previous thoracic surgery
Rare causes: systemic lupus erythematosus, ankylosing spondylitis

The common underlying mechanism is long-term inflammation of the pleura, leading to a thickened, fibrotic pleural membrane. Impaired drainage of pleural fluid allows cholesterol and lipids to accumulate over time.

Symptoms

The symptoms of pseudochylothorax are often non-specific and depend on the size of the effusion and the underlying disease. Common complaints include:

Shortness of breath (dyspnea), especially during physical activity
Chest pain or a feeling of pressure in the chest
Dry cough
General fatigue and weakness
Occasionally fever in cases of concurrent infection
Unintentional weight loss (when tuberculosis or malignancy is the underlying cause)

Diagnosis

Diagnosing pseudochylothorax requires several diagnostic steps:

Imaging

Chest X-ray: Detection of pleural effusion
Computed tomography (CT): Assessment of pleural thickening and exclusion of malignancy
Ultrasound: Guidance for pleural puncture

Thoracentesis and Laboratory Analysis

Thoracentesis (pleural puncture) is the most important diagnostic step. The retrieved fluid is analyzed for:

Macroscopic appearance: milky, turbid, whitish fluid
Cholesterol concentration: elevated (often above 200 mg/dl)
Triglyceride concentration: normal or low (to exclude true chylothorax)
Cholesterol-to-triglyceride ratio: greater than 1 (typical of pseudochylothorax)
Lecithin-globulin complexes may be identified
Cytology, microbiology, and additional markers to identify the underlying cause

Differentiation from True Chylothorax

The most important differential diagnosis is true chylothorax. In chylothorax, triglyceride levels are elevated (above 110 mg/dl) while cholesterol is normal. In pseudochylothorax, the pattern is reversed, with high cholesterol and normal or low triglycerides.

Treatment

Treatment of pseudochylothorax is primarily directed at the underlying cause and the severity of symptoms.

Treating the Underlying Condition

For tuberculosis: Anti-tuberculous drug therapy (e.g., isoniazid, rifampicin)
For rheumatoid arthritis: Anti-rheumatic therapy (DMARDs, corticosteroids)
For malignancy: Oncological treatment (chemotherapy, radiation therapy)

Drainage Procedures

Therapeutic thoracentesis: Single or repeated drainage for symptom relief
Chest tube drainage: For large or symptomatic effusions
Pleurodesis: Chemical adhesion of the pleural layers to prevent recurrence (e.g., using talc)

Surgical Interventions

Decortication: Surgical removal of the thickened pleural peel in cases of significantly impaired lung function
Video-assisted thoracoscopic surgery (VATS): A minimally invasive surgical option

Prognosis

The prognosis of pseudochylothorax depends strongly on the underlying condition. If the root cause is successfully treated, the effusion may resolve. However, complete resolution is rare in cases with long-standing fibrotic pleural disease. Regular follow-up examinations are recommended.

References

Hillerdal G. - Chylothorax and pseudochylothorax. In: European Respiratory Journal, 1997; 10(5): 1157-1162.
Staats BA, Ellefson RD, Budahn LL et al. - The lipoprotein profile of chylous and nonchylous pleural effusions. In: Mayo Clinic Proceedings, 1980; 55(11): 700-704.
Light RW. - Pleural Diseases. 6th edition. Lippincott Williams and Wilkins, 2013.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category